UnitedHealth Group (NYSE:UNH) Price Target Cut to $560.00 by Analysts at Barclays

UnitedHealth Group (NYSE:UNH - Get Free Report) had its price objective dropped by analysts at Barclays from $642.00 to $560.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage presently has an "overweight" rating on the healthcare conglomerate's stock. Barclays's target price points to a potential upside of 31.86% from the stock's current price.

A number of other research analysts have also recently commented on the company. HSBC raised UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 target price on the stock in a research note on Friday, January 10th. Mizuho boosted their target price on shares of UnitedHealth Group from $600.00 to $650.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. StockNews.com raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Thursday, January 23rd. Truist Financial increased their price target on UnitedHealth Group from $610.00 to $660.00 and gave the stock a "buy" rating in a research report on Friday, April 11th. Finally, KeyCorp reaffirmed an "overweight" rating and issued a $650.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Three research analysts have rated the stock with a hold rating, nineteen have given a buy rating and three have issued a strong buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Buy" and an average target price of $603.05.

UnitedHealth Group Price Performance

Shares of UNH stock traded down $3.26 on Monday, reaching $424.70. The company's stock had a trading volume of 7,608,478 shares, compared to its average volume of 4,455,390. The stock's fifty day simple moving average is $506.92 and its 200-day simple moving average is $537.23. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $388.48 billion, a price-to-earnings ratio of 27.40, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. UnitedHealth Group has a 1 year low of $417.12 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $109.58 billion for the quarter, compared to analysts' expectations of $111.56 billion. During the same quarter in the previous year, the company posted $6.91 EPS. Analysts forecast that UnitedHealth Group will post 29.54 earnings per share for the current fiscal year.

Institutional Trading of UnitedHealth Group

A number of hedge funds have recently modified their holdings of the stock. Geode Capital Management LLC lifted its stake in shares of UnitedHealth Group by 1.6% in the 4th quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate's stock valued at $10,068,869,000 after purchasing an additional 319,515 shares during the period. Capital International Investors raised its position in shares of UnitedHealth Group by 6.2% in the fourth quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate's stock worth $7,899,905,000 after acquiring an additional 906,365 shares during the period. Norges Bank purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at about $6,375,744,000. Northern Trust Corp boosted its position in UnitedHealth Group by 12.5% during the fourth quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate's stock worth $4,807,527,000 after purchasing an additional 1,058,488 shares in the last quarter. Finally, Franklin Resources Inc. increased its position in shares of UnitedHealth Group by 10.7% in the fourth quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate's stock valued at $4,514,178,000 after buying an additional 861,854 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.